MyFinsight
Home
Blog
About
Contact
Download
Download image
Building
$1,187,836K
Laboratory Equipment
$309,471K
Machinery And Equipment
$273,769K
Software And Software
Development Costs
$124,136K
Leasehold Improvements
$76,568K
Land
$71,434K
Property and equipment,
at cost
$2,043,214K
2031 and thereafter
$31,239K
2030
$6,293K
2028
$6,293K
2027
$6,293K
2026
$6,293K
2027-Cost Of Sales
$6,226K
2027-Selling General And
Administrative Expenses
$67K
Construction in progress
$127,159K
Cash and cash
equivalents
$4,547,530K
Accounts receivable, net
$865,080K
Inventories, net
$608,227K
Prepaid expenses and
other current assets
$212,752K
Property, plant and
equipment, net
$1,641,678K
Operating lease
right-of-use assets
$148,184K
Other non-current
assets
$102,418K
Intangible assets, net
$62,704K
Less accumulated
depreciation
$528,695K
Total current assets
$6,233,589K
Total non-current
assets
$1,954,984K
Total assets
$8,188,573K
Total liabilities and
shareholders equity
$8,188,573K
Total shareholders
equity
$4,361,194K
Total liabilities
$3,827,379K
Accumulated deficit
-$8,319,903K
Accumulated other
comprehensive loss
-$78,184K
Additional paid-in capital
$12,759,137K
Total non-current
liabilities
$1,998,549K
Total current
liabilities
$1,828,830K
Ordinary shares, 0.0001
par value per share...
$144K
Long-term debt
$961,913K
Sale of future
royalty liability,...
$850,242K
Other long-term
liabilities
$80,245K
Deferred tax liabilities
$53,209K
Operating lease
liabilities, non-current...
$52,940K
Accrued expenses and
other payables
$1,109,120K
Accounts payable
$479,035K
Research and development
cost share...
$64,345K
Short-term debt
$57,293K
Sale of future
royalty liability,...
$56,714K
Tax payable
$41,625K
Operating lease
liabilities, current portion
$20,698K
Back
Back
Balance Sheet
source: myfinsight.com
BeOne Medicines Ltd. (ONC)
BeOne Medicines Ltd. (ONC)